Future Manufacturing Hub in Targeted Healthcare

By 2025 targeted biological medicines will transform the precision of healthcare prescription, improve patient care and quality of life. The current "one-size-fits-all" approach to drug development is being challenged by the growing ability to create stratified and personalised medicines targeted to specific sub-populations and even individuals.

The Hub will provide the manufacturing infrastructure and capabilities needed to enable UK manufacturers to exploit fully medical precision advances, through new technologies, skilled personnel, IP and spin-outs. The Hub and its Spokes will address the manufacturing challenges to ensure that new targeted biological medicines can be developed quickly and manufactured at a cost affordable to society.

Key Academic and Industrial Partners


  • University College London
  • University of Warwick
  • Imperial College London
  • The University of Manchester
  • University of Nottingham
  • Loughborough University


  • Albumedix
  • Allergan
  • AstraZeneca/Medimmune
  • Autolus
  • BIA Separation
  • BioIndustry Association
  • BiologicB Consulting
  • BioPharm Services
  • Cell & Gene Therapy Catapult
  • DeltaDot
  • Eli Lilly
  • FloDesignSonics
  • Francis BioPharm Consulting
  • Fujifilm Diosynth Biotechnologies
  • GlaxoSmithKline (Biopharma) & GlaxoSmithKline (Cell/Gene Therapy)
  • KTN Ltd
  • LGC
  • Lonza
  • Merck & Co.
  • Merck KGaA
  • MMIP
  • Novo Nordisk
  • Oxford BioMedica
  • Perceptive
  • Pfizer
  • Puridify
  • Purolite Ltd
  • Reneuron
  • Roche
  • Sartorius
  • Sutro Biopharma
  • Tillingbourne Consulting
  • TrakCel
  • UCB Pharma
  • Wyatt


  • Professor Nigel Titchener-Hooker, Director
  • Tel: +44 (0)20 7679 7293
  • E-mail: nigelth@ucl.ac.uk

You must select the video player for these keys to function.

Key Action
space play/pause
f fullscreen
shift + left arrow slower
shift + right arrow faster
down arrow volume down
up arrow volume up
m mute
left arrow seek backward
right arrow seek forward
. (period) seek to previous position
number seek to numbertimes 10 percent of duration

Watch on YouTube